Union Savings Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Sell
1,477
-156
-10% -$159K 0.71% 23
2026
Q1
$1.5M Sell
1,633
-17
-1% -$17.2K 0.66% 25
2025
Q4
$1.77M Buy
+1,650
New +$1.58M 0.77% 22
2025
Q2
$1.13M Sell
1,531
-392
-20% -$305K 0.52% 36
2025
Q1
$1.59M Sell
1,923
-45
-2% -$37.4K 0.78% 24
2024
Q4
$1.52M Sell
1,968
-30
-2% -$24.8K 0.75% 25
2024
Q3
$1.77M Buy
1,998
+235
+13% +$211K 0.87% 21
2024
Q2
$1.6M Sell
1,763
-590
-25% -$472K 0.84% 20
2024
Q1
$1.83M Sell
2,353
-197
-8% -$140K 0.96% 19
2023
Q4
$1.49M Sell
2,550
-310
-11% -$181K 0.84% 25
2023
Q3
$1.54M Sell
2,860
-25
-0.9% -$12.9K 0.96% 22
2023
Q2
$1.31M Buy
+2,885
New +$1.21M 0.78% 29

Other funds holding LLY

Union Savings Bank's LLY Position: Q2 2026 in Review

Union Savings Bank reduced its Eli Lilly (LLY) stake by 9.6% in Q2 2026, selling an estimated $159K and leaving 1,477 shares worth $1.77M. The position accounts for 0.71% of the portfolio, ranked #23.

Union Savings Bank first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.83M in Q1 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Union Savings Bank held 1,477 shares of Eli Lilly worth $1.77M as of Q2 2026.
  • Union Savings Bank sold 156 Eli Lilly shares in Q2 2026, an estimated $159K.
  • Eli Lilly made up 0.71% of Union Savings Bank's portfolio in Q2 2026, its #23 holding.
  • Union Savings Bank first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Union Savings Bank's Eli Lilly position peaked at $1.83M in Q1 2024.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.